The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells

BMC Cancer

Jing Wang¹  Xiao-Hong Liu¹  Zi-Jian Yang¹  Bing Xie¹  Yi-Sheng Zhong¹ 

[1] Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, 197 Ruijin No. 2 Road, Shanghai 200025, PR China

关键词: ROCK;    Retinoblastoma;    Invasion;    Adhesion;   

Others  :  859068
DOI  :  10.1186/1471-2407-14-89

 received in 2013-10-07, accepted in 2014-02-12,  发布年份 2014

【 摘 要 】

Background

Retinoblastoma (Rb) is the most common intraocular tumor in childhood worldwide. It is a deadly pediatric eye cancer. The main cause of death in Rb patients is intracranial and systemic metastasis. ROCK is the main downstream effector of Ras-homologous (Rho) family of GTPases which are involved in many cellular functions, such as cell proliferation, invasion and metastasis. Overexpression of ROCK promotes invasion and metastasis of many solid tumors. However, the effect of ROCK in Rb is largely unknown.

Methods

ROCK-1 and ROCK-2 mRNA expression in Y79 cell lines were examined by RT-PCR. Protein expression in the Y79 cell line were examined by western blot analyses. ROCK-1 and ROCK-2 siRNA were transfected into Y79 cells with Lipofectamine 2000. Cell proliferation was evaluated by CCK-8 assay after exposure to ROCK inhibitor (Y-27632). We examined the effect of ROCK inhibitors (Y-27632, ROCK-1 and ROCK-2 siRNA) on Y79 cell adhesive capacity by cell adhesion assay. Cell invasion assay through matrigel was used to study the effect of ROCK inhibitors on Y79 cell invasive capacity.

Results

The expression of mRNA of ROCK-1 was more than that of ROCK-2 in the Y79 cell line. The protein expression levels of ROCK-1 and ROCK-2 were downregulated in the cells transfected with siRNA. Y-27632 treatment didn’t lead to any changes of Y79 cells proliferation. Adhesive ability of Y79 cells was enhanced following Y-27632 or ROCK-1 siRNA treatment. The invasive capacity of Y79 cells showed an inverse relationship with increasing Y-27632 concentration. Invasiveness of Y79 cells also decreased in Y79 cells transfected with ROCK-1 siRNA. However, there was no change in adhesive ability or invasive capacity in Y79 cells transfected with siRNA against ROCK-2.

Conclusions

The findings of this study demonstrate that ROCK-1 protein plays a key role in regulating metastasis and invasion of Y79 cells, suggesting that the ROCK-1 dependent pathway may be a potential target for therapy of Rb.

【 授权许可】

   
2014 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG, Shields C: Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr 2012, 10(3):175-181.
• [2]Abramson DH: Retinoblastoma: diagnosis and management. CA Cancer J Clin 1982, 32(3):130-140.
• [3]Lawler K, Foran E, O’Sullivan G, Long A, Kenny D: Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am J Physiol Cell Physiol 2006, 291(4):C668-C677.
• [4]Schofield AV, Steel R, Bernard O: Rho-associated Coiled-coil Kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration. J Biol Chem 2012, 287(52):43620-43629.
• [5]Nakagawa H, Yoshioka K, Miyahara E, Fukushima Y, Tamura M, Itoh K: Intrathecal administration of Y-27632, a specific Rho-associated kinase inhibitor, for rat neoplastic meningitis. Mol Cancer Res 2005, 3(8):425-433.
• [6]Riento K, Ridley AJ: Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003, 4(6):446-456.
• [7]Shimada T, Nishimura Y, Nishiuma T, Rikitake Y, Hirase T, Yokoyama M: Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci 2007, 53(3):125-134.
• [8]Ro¨sel D, Bra’bek J, Tolde O, Mierke CT, Zitterbart DP, Raupach C, Bicanova’ K, Kollmannsberger P, Pankova’ D, Vesely P, et al.: Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 2008, 6(9):1410-1420.
• [9]Xue F, Takahara T, Yata Y, Xia Q, Nonome K, Shinno E, Kanayama M, Takahara S, Sugiyama T: Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner. Hepatol Res 2008, 38(8):810-817.
• [10]Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC: ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 2007, 87(11):1149-1158.
• [11]Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG: The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 2008, 33(3):585-593.
• [12]Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S: Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000, 57(5):976-983.
• [13]Routhier A, Astuccio M, Lahey D, Monfredo N, Johnson A, Callahan W, Partington A, Fellows K, Ouellette L, Zhidro S, et al.: Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth. Oncol Rep 2010, 23(3):861-867.
• [14]Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S: An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999, 5(2):221-225.
• [15]Kruger NJ: The Bradford method for protein quantitation. Methods Mol Biol 1994, 32:9-15.
• [16]Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, et al.: The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 1996, 15(8):1885-1893.
• [17]Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S: ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996, 392(2):189-193.
• [18]Scott RW, Olson MF: LIM. kinases: function, regulation and association with human disease. J Mol Med 2007, 85(6):555-568.
• [19]Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K: Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 2000, 275(5):3577-3582.
• [20]Sumi T, Matsumoto K, Nakamura T: Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. J Biol Chem 2001, 276(1):670-676.
• [21]Michael Olson F: Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008, 20(2):242-248.
• [22]Worthylake RA, Lemoine S, Watson JM, Burridge K: RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 2001, 154(1):147-160.
• [23]Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo AP: Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 2000, 269(3):652-659.
• [24]Worthylake RA, Burridge K: RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem 2003, 278(15):13578-13584.
• [25]Dawe HR, Minamide LS, Bamburg JR, Cramer LP: ADF/cofilin controls cell polarity during fibroblast migration. Curr Biol 2003, 13(3):252-257.